CIK 0001774857 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aardvark Therapeutics, Inc.
Sign in to watch- Ticker
- AARD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821606367
- Phone
- (858) 225-7696
- Business address
- 4370 LA JOLLA VILLAGE DRIVE, SUITE 1050, SAN DIEGO, CA, 92122
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $394,957
- in 1 filing, $395K under 10b5-1 plans
Net −$394,957. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-06 | Sun Nelson See Remarks | Grant or award · Stock Option (right to buy) | +70,549 | 70,549 | ||
| 2026-11-06 | Sun Nelson See Remarks | Returned to the company · Stock Option (right to buy) | −70,549 | 0 | ||
| 2026-11-06 | Sun Nelson See Remarks | Grant or award · Stock Option (right to buy) | +209,826 | 209,826 | ||
| 2026-11-06 | Sun Nelson See Remarks | Returned to the company · Stock Option (right to buy) | −209,826 | 0 | ||
| 2026-11-06 | Sun Nelson See Remarks | Grant or award · Stock Option (right to buy) | +23,719 | 23,719 | ||
| 2026-11-06 | Sun Nelson See Remarks | Returned to the company · Stock Option (right to buy) | −23,719 | 0 | ||
| 2026-09-11 | Sun Nelson See Remarks | Sale 10b5-1 | −62,000 | $5.18 | $321K | 35,475 |
| 2026-09-10 | Sun Nelson See Remarks | Sale 10b5-1 | −14,754 | $5.00 | $74K | 97,475 |
| 2026-02-09 | Sun Nelson Chief Financial Officer | Grant or award · Stock option (right to buy) | −70,549 | 70,549 | ||
| 2025-12-11 | Sun Nelson Chief Financial Officer | Purchase | +3,000 | $14.40 | $43K | 108,484 |
| 2025-09-09 | Sun Nelson Chief Financial Officer | Purchase | +6,000 | $8.07 | $48K | 105,484 |
| 2025-06-11 | Sun Nelson Chief Financial Officer | Grant or award · Stock Option (right to buy) | +209,826 | 209,826 | ||
| 2025-02-14 | Sun Nelson Chief Financial Officer | Conversion | +7,001 | 89,484 | ||
| 2025-02-14 | Sun Nelson Chief Financial Officer | Purchase | +10,000 | $16.00 | $160K | 99,484 |
| 2025-02-14 | Sun Nelson Chief Financial Officer | Conversion · Series C Convertible Preferred Stock | −59,332 | 0 |
Page 1 of 1 · 15 trades